<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Protein tyrosine phosphatase nonreceptor type 14 (PTPN14) is frequently mutated in a variety of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the cell signaling pathways regulated by PTPN14 largely remain to be elucidated </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we identify a list of potential substrates of PTPN14 using a phospho-proteomic approach </plain></SENT>
<SENT sid="3" pm="."><plain>We show that p130 Crk-associated substrate (p130Cas) is a direct substrate of PTPN14 and that PTPN14 specifically regulates p130Cas phosphorylation at <z:chebi fb="0" ids="32789">tyrosine residue</z:chebi> 128 (Y128) in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells </plain></SENT>
<SENT sid="4" pm="."><plain>We engineered <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells homozygous for a p130Cas Y128F knock-in mutant and found that these cells exhibit significantly reduced migration and colony formation, impaired anchorage-independent growth, slower xenograft <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice and have decreased phosphorylation of AKT </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, we demonstrate that SRC phosphorylates p130Cas Y128 and that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines harboring high levels of pY128Cas are more sensitive to SRC family kinase inhibitor <z:chebi fb="0" ids="49375">Dasatinib</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that p130Cas Y128 phosphorylation may be exploited as a predictive marker for <z:chebi fb="0" ids="49375">Dasatinib</z:chebi> response in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>In aggregate, our studies reveal a novel signaling pathway that has an important role in colorectal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>.Oncogene advance online publication, 18 June 2012; doi:10.1038/onc.2012.220 </plain></SENT>
</text></document>